Evidence map›Paper›PMID 37059914›Full record

ArticleNature genetics2023

Author Correction: The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression.

Daniel Schramek, Athanassios Kotsinas, Arabella Meixner, Teiji Wada, Ulrich Elling, J Andrew Pospisilik, G Gregory Neely, Ralf-Harun Zwick, Verena Sigl, Guido Forni and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Daniel SchramekInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Athanassios KotsinasDepartment of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece.
Arabella MeixnerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Teiji WadaInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Ulrich EllingInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
J Andrew PospisilikInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
G Gregory NeelyGarvan Institute of Medical Research, Darlinghurst, Sydney, Australia.
Ralf-Harun ZwickDepartment of Respiratory and Critical Care Medicine, Otto Wagner Hospital, Vienna, Austria.
Verena SiglInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Guido ForniMolecular Biotechnology Center, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Manuel SerranoSpanish National Cancer Research Centre (CNIO), Madrid, Spain.
Vassilis G GorgoulisDepartment of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece.
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria. josef.penninger@imba.oeaw.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37059914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.